Fidelity Investments’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLN
SL
Fidelity Investments's SLN Position: Q3 2026 in Review
Fidelity Investments opened a new position in Silence Therapeutics (SLN) in Q3 2026: 4,710,812 shares worth $51.5M. The stake represents ﹤0.01% of the portfolio and ranks #1488 among its holdings.
92 funds tracked by Wall St. Rank hold SLN as of Q3 2026.
- Fidelity Investments held 4,710,812 shares of Silence Therapeutics worth $51.5M as of Q3 2026.
- Silence Therapeutics was a new Fidelity Investments position in Q3 2026.
- Silence Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1488 holding.
- 92 funds tracked by Wall St. Rank held Silence Therapeutics as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.